Thrombocytopenia Associated with Heparin-coated Catheters in Patients with Heparin-associated Antiplatelet Antibodies

Thrombocytopenia was associated with the presence of heparin-coated pulmonary artery catheters in 12 patients with heparin-associated antiplatelet antibodies. The thrombocytopenia persisted so long as the heparin-coated catheters were in place, even when all other sources of heparin were discontinued. The high morbidity and mortality associated with heparin-induced thrombocytopenia mandates that heparin administration cease and that all heparin-coated catheters be removed from patients with heparin-associated antiplatelet antibodies.